(19)
(11) EP 2 938 638 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
26.12.2018 Bulletin 2018/52

(45) Mention of the grant of the patent:
14.11.2018 Bulletin 2018/46

(21) Application number: 13814180.9

(22) Date of filing: 27.12.2013
(51) International Patent Classification (IPC): 
C08B 37/00(2006.01)
 C08J 3/28(2006.01)
(86) International application number:
PCT/EP2013/078061
(87) International publication number:
WO 2014/102332 (03.07.2014 Gazette 2014/27)

(54)

DEPOLYMERISATION OF ALGINIC ACID

DEPOLYMERISATION VON ALGININSÄURE

DÉPOLYMÉRISATION D'ACIDE ALGINIQUE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 28.12.2012 EP 12199699
28.12.2012 US 201261746853 P

(43) Date of publication of application:
04.11.2015 Bulletin 2015/45

(73) Proprietor: DuPont Nutrition Biosciences ApS
1411 Copenhagen K (DK)

(72) Inventors:
  • KLINGER, Markus
    3500 Værløse (DK)
  • AHMED, Toqeer
    8220 Brabrand (DK)
  • JUUL, Anne Grete
    8660 Skanderborg (DK)
  • STENBÆK, Dorthe
    8220 Brabrand (DK)

(74) Representative: Dr. Weitzel & Partner 
Patent- und Rechtsanwälte mbB Friedenstrasse 10
89522 Heidenheim
89522 Heidenheim (DE)


(56) References cited: : 
KR-A- 20010 100 250
 US-A1- 2011 028 708
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).